Risuteganib Dosing Calculator
Risuteganib (Luminate/ALG-1001): first-in-class integrin-regulating peptide for dry AMD.
Pre-filled with the most-reported clinical reconstitution protocol for Risuteganib. See how 1 mL and 2 mL of bacteriostatic water change concentration and syringe-draw volume, then adjust the calculator below for your own vial.
Quick answer · Clinical protocol
A 5 mg vial of Risuteganib reconstituted with 2 mL of bacteriostatic water yields a concentration of 2.50 mg/mL. At that concentration, a 1 mg dose of Risuteganib equals 40 units on a U-100 insulin syringe (0.400 mL). Risuteganib is typically administered once daily.
Risuteganib reconstitution: 1 mL vs 2 mL bac water
Bacteriostatic water volume is flexible. Less water means higher concentration and smaller injection volumes; more water means lower concentration and easier dose precision. Both options below are valid for a 5 mg vial.
| BAC water added | Concentration | Volume per 1 mg dose | Draw on U-100 syringe (units) |
|---|---|---|---|
| 1 mL | 5.00 mg/mL | 0.200 mL | 20 units |
| 2 mL | 2.50 mg/mL | 0.400 mL | 40 units |
Calculate your Risuteganib dose
Alternative Risuteganib protocols
Beyond the default above, Risuteganib is also reported in the following protocols. Use these as starting points and recalculate with the tool above.
Intermediate Dry AMD (Phase 2b/3 Design)
Clinical- Dose
- 1.0 mg intravitreal injection.
- Frequency
- Every 12 weeks
- Duration
- 5 intravitreal injections 12 weeks apart, with continued treatment during the follow-up safety period. Primary endpoint assessed at 52 weeks.
FDA Special Protocol Assessment agreement received for this trial design. Study ongoing.
Risuteganib reconstitution & storage
Risuteganib is supplied as a sterile solution for intravitreal injection. No reconstitution is required. It is administered as a ready-to-use formulation by a qualified ophthalmologist.
Storage conditions for the clinical formulation have not been publicly disclosed. Clinical supplies are managed under controlled conditions per clinical trial protocols.
Risuteganib dosing FAQ
How much bacteriostatic water should I add to a 5 mg vial of Risuteganib?
The community standard is 2 mL of bacteriostatic water for a 5 mg Risuteganib vial. That gives a concentration of 2.50 mg/mL, so a 1 mg dose is 40 units on a U-100 insulin syringe. Adding 1 mL instead doubles the concentration to 5.00 mg/mL and halves the draw to 20 units. Less water = smaller injection volume but harder to measure precisely.
How many syringe units is a 1 mg dose of Risuteganib?
On a standard U-100 insulin syringe, a 1 mg dose of Risuteganib is 40 units when the 5 mg vial is reconstituted with 2 mL of bacteriostatic water (2.50 mg/mL). If you use 1 mL of bac water instead, draw 20 units (5.00 mg/mL).
What is the standard Risuteganib dose?
Clinical protocols for Risuteganib typically use 1 mgâ2 mg once daily via subcutaneous injection. 1 mg is a common starting dose. Investigational dosing. Phase 2b/3 design uses 5 intravitreal injections 12 weeks apart with continued treatment during follow-up.
How long does a vial of Risuteganib last at 1 mg once daily?
A 5 mg vial of Risuteganib contains roughly 5 doses at 1 mg per injection. At once daily dosing, that is approximately 5 days (about 1 weeks) of supply per vial. Reconstituted Risuteganib should generally be used within 28 days when refrigerated.
Where do you inject Risuteganib?
Risuteganib is typically injected subcutaneously. Common sites reported in the literature and by users include: Intravitreal injection only. Administered into the vitreous cavity of the eye by a qualified retinal specialist under sterile conditions. This is not a subcutaneous, intramuscular, or intravenous injection.. Rotate sites with each injection to reduce localized irritation.
Can I use sterile water instead of bacteriostatic water for Risuteganib?
Bacteriostatic water (containing 0.9% benzyl alcohol as a preservative) is strongly preferred for multi-dose vials like Risuteganib because it inhibits microbial growth and lets a single vial be used over multiple weeks. Sterile water has no preservative and should generally be reserved for single-use preparations only.
More on Risuteganib
Risuteganib overview
Mechanism of action, primary uses, and research summary
Risuteganib dosing protocols
Full clinical and research-based dosing reference
Risuteganib community protocols
Real-world usage patterns from peptide communities
Risuteganib side effects
Reported adverse effects and safety considerations
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.